Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative analysis of trastuzumab (Aryogen) with Herceptin
IRCT201208116302N4Phase 3Completed
- Sponsor
- AryoGen Biopharma
- Start
- Apr 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of trastuzumab in breast cancer (2 arms), sponsored by AryoGen Biopharma. Started Apr 2013; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT201208116302N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201208116302N4.